Palliative chemotherapy

Optimising end of life care requires an individualised approach

BMJ 2014; 348 doi: http://dx.doi.org/10.1136/bmj.g2312 (Published 25 March 2014)

Cite this as: BMJ 2014;348:g2312

1. Hilde M Buiting, researcher in palliative decision-making1,
2. Gabe S Sonke, medical oncologist2

Author Affiliations

1. h.buiting@iknl.nl

Wright and colleagues conclude that patients receiving palliative chemotherapy who have an estimated life expectancy of six months are more likely than those not receiving palliative chemotherapy to experience intensive medical end of life care.

The authors previously showed that end of life discussions in early stage disease are associated with decreased “aggressive” care.

We support the identification of early predictors for intensive medical …